Cue Biopharma Reports Fourth Quarter and Full Year 2023

BOSTON, April 08, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, today...

Related Keywords

Boston , Massachusetts , United States , Jonathan Pappas , Marie Campinell , Daniel Passeri , Corporate Communications , Lifesci Communications , Society For Immunotherapy , Drug Administration , Nasdaq , Cue Biopharma Inc , Linkedin , Wilm Tumor , Annual Meeting , Annual Healthcare Life Sciences Conference , Ono Pharmaceutical , Investigational New Drug , Selective Targeting , Private Securities Litigation Reform Act , Risk Factors , Financial Condition , Annual Report , Quarterly Report , Markets ,